Press release
mAb Biosimilars Market Thrives as Cost-effective Alternatives Fuel Adoption | Samsung Bioepis | Amgen | Biocon
mAb Biosimilars Market OverviewmAb Biosimilars Market is estimated to grow from USD 9.4 billion in 2025 to USD 22.7 billion by 2032, at a CAGR of 13.3%.
Coherent Market Insights is pleased to release its latest mAb Biosimilars Market research report, offering an in-depth analysis of the U.S. mAb Biosimilars Market Landscape from 2025 to 2032. This report delivers reliable projections across national and regional levels, encompassing supply chain shifts, payer-provider dynamics, and competitive intelligence. The U.S. Healthcare Industry continues to advance rapidly, fueled by the rising burden of chronic conditions, growing healthcare expenditure, and innovations in biotechnology and digital health. Our report presents a comprehensive assessment of market forces-from value-based care and patient-centric models to policy and regulatory transformations shaping the future of healthcare delivery.
💡Request Your Sample Copy of the US Tariff Impact Analysis Now: - https://www.coherentmarketresearch.com/samplepages/90517
Driving Strategic and Clinical Excellence
This healthcare-focused report serves stakeholders across the care continuum-including providers, payers, investors, and executives-with actionable market intelligence on the evolving U.S. Health Ecosystem. It provides segmentation by therapeutic specialties, care delivery models, and payer categories. Insights are validated by clinical experts and policy analysts. Methodology includes clinical trial reviews, reimbursement trends, and patient outcome benchmarking-supported with data visualizations, dashboards, and region-specific analysis.
Key therapeutic areas covered include oncology, cardiovascular disease, and rare disorders, along with rising trends such as AI-enabled diagnostics, telehealth adoption, and personalized medicine. This report enables informed decision-making aligned with changing reimbursement models, regulatory standards, and patient expectations in the U.S. mAb Biosimilars Market.
📌 Key Healthcare Companies Profiled:
◘ Amgen
◘ Samsung Bioepis
◘ Biocon
◘ Pfizer
◘ Sandoz.
⏩ Market Segmentation:
Product Type: Monoclonal Antibodies, Insulin, Erythropoietin, Somatropin
Application: Oncology, Chronic and Autoimmune Disorders
Manufacturer: In-house, Contract Research and Manufacturing Services
📊 Report Scope
This report provides a dual focus on the U.S. and Global mAb Biosimilars Markets, analyzing federal and state policy developments, payer reforms, CMS programs, and FDA regulatory updates. It examines historical benchmarks and forecasts for revenue and patient volumes. Technologies reviewed include EHR systems, medical devices, precision therapeutics, and mobile health (mHealth) platforms.
The report also evaluates equity initiatives, provider shortages, and insurance coverage disparities, offering data-driven strategies for navigating risks and enabling growth across the U.S. healthcare economy.
📌 Research Methodology:
Our research combines primary interviews with healthcare providers, health system executives, and policymakers, with secondary data from CDC, CMS, FDA, and leading peer-reviewed journals. This ensures that the mAb Biosimilars Market analysis remains both clinically accurate and business-relevant.
🗺️ U.S. Regional Market Deep Dive:
Northeast: New York, Massachusetts, Pennsylvania
Midwest: Illinois, Ohio, Michigan
South: Texas, Florida, Georgia
West: California, Washington, Arizona
Each region includes evaluation of health system infrastructure, demographic needs, reimbursement trends, and digital innovation readiness.
✅Get Up to 70% Discount on the US Tariff Impact Analysis Report : https://www.coherentmarketinsights.com/promo/buynow/90517
Read More Trending Articles
Monoclonal Antibody Therapeutics Market - https://www.globenewswire.com/news-release/2023/04/12/2645360/0/en/Monoclonal-Antibody-Therapeutics-Market-to-Surpass-US-534-26-Billion-by-2030-Says-Coherent-Market-Insights-CMI.html#:~:text=Burlingame%2C%20April%2012%2C%202023%20(,period%20(2023%2D2030).
Neurofeedback Market - https://www.globenewswire.com/news-release/2023/04/13/2646204/0/en/Neurofeedback-Market-to-Surpass-US-2-056-9-Million-by-2030-Says-Coherent-Market-Insights-CMI.html#:~:text=Burlingame%2C%20April%2013%2C%202023%20(,period%20(2023%2D2030).
Surgical Drills Market - https://www.globenewswire.com/news-release/2023/04/14/2647040/0/en/Surgical-Drills-Market-to-Surpass-US-1-030-1-Million-by-2030-Says-Coherent-Market-Insights-CMI.html#:~:text=Burlingame%2C%20April%2014%2C%202023%20(,period%20(2023%2D2030).
Over the Counter (OTC) Analgesics Market - https://www.globenewswire.com/news-release/2023/06/23/2693711/0/en/Over-the-Counter-OTC-Analgesics-Market-to-Reach-US-39-74-Billion-by-2030-Says-Coherent-Market-Insights.html
Pigmentation Disorders Treatment Market - https://www.globenewswire.com/en/news-release/2023/06/26/2694516/0/en/Pigmentation-Disorders-Treatment-Market-to-Reach-US-9-68-Billion-by-2028-Coherent-Market-Insights.html
💬 Key Questions Addressed in This Healthcare Report:
(1) Who are the leading healthcare companies in the U.S. market?
(2) What technological and clinical trends will shape healthcare delivery by 2032?
(3) How are providers responding to regulatory shifts from CMS and FDA?
(4) What payer strategies are optimizing outcomes and lowering costs?
(5) Which segments are most influenced by precision medicine and remote monitoring?
(6) How will healthcare policy reforms impact the U.S. economy?
(7) What is the projected growth trajectory for the U.S. healthcare sector?
✍️ Report Author:
Vaagisha is a seasoned healthcare content editor with over three years of experience in medical market analysis. With a life sciences background and a sharp editorial lens, she ensures every report is clinically precise, regulatory-compliant, and strategically aligned for healthcare stakeholders.
About Coherent Market Insights
Coherent Market Insights is a globally trusted mAb Biosimilars Market intelligence and consulting firm offering evidence-based research reports and strategic advisory services. Specializing in pharmaceuticals, medical devices, digital health, and hospital systems, we support health systems, biopharma leaders, policymakers, and medtech innovators with insights tailored for a post-pandemic landscape.
☎️ Contact Us:
Mr. Shah
Senior Client Partner - Business Development
Coherent Market Insights
📞 US: +1-206-701-6702
📞 UK: +44-020-8133-4027
📞 AUS: +61-2-4786-0457
📞 India: +91-848-285-0837
✉ Email: sales@coherentmarketinsights.com
🌐 Website: www.coherentmarketinsights.com
Follow us: LinkedIn | Twitter
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release mAb Biosimilars Market Thrives as Cost-effective Alternatives Fuel Adoption | Samsung Bioepis | Amgen | Biocon here
News-ID: 4011491 • Views: …
More Releases from Coherent Market Insights

Meal Replacement Market Market to Hit $22.01 Bn by 2032 with a CAGR of 5.8% |Abb …
The Meal Replacement Market is estimated to be valued at USD 14.82 Bn in 2025 and is expected to reach USD 22.01 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 5.8% from 2025 to 2032.
The latest report from Coherent Market Insights examines the growth prospects of the Meal Replacement Market Market from 2025 to 2032. This in-depth analysis covers industry size, market share, business trends, key growth…

Deep Cycle Battery Market, Market Outlook : Projected to Exceed USD 4.73 Billion …
The deep cycle battery market is estimated to be valued at USD 2.77 billion in 2025 and is expected to reach USD 4.73 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.9% from 2025 to 2032.
The latest report from Coherent Market Insights examines the growth prospects of the Deep Cycle Battery Market, Market from 2025 to 2032. This in-depth analysis covers industry size, market share, business…

Consumer Electronics Packaging Market Market Projected to Witness Huge Growth by …
The consumer electronics packaging market is estimated to be valued at USD 26.57 Bn in 2025 and is expected to reach USD 81.72 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 17.4% from 2025 to 2032.
The latest report from Coherent Market Insights examines the growth prospects of the Consumer Electronics Packaging Market Market from 2025 to 2032. This in-depth analysis covers industry size, market share, business trends,…

Ceramic Armor Market Market Set to Witness Significant Growth by 2025-2032 |Koni …
The global ceramic armor market is estimated to be valued at USD 2.75 Bn in 2025 and is expected to reach USD 4.08 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.8% from 2025 to 2032.
The latest report from Coherent Market Insights examines the growth prospects of the Ceramic Armor Market Market from 2025 to 2032. This in-depth analysis covers industry size, market share, business trends,…
More Releases for Biosimilars
Transformative Trends Impacting the Biosimilars Market Landscape: Innovative Pro …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Biosimilars Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The dimensions of the biosimilars market have been rapidly expanding over the last couple of years. The escalation, from a worth of $18.65 billion in 2024 to an estimated value of $21.95 billion in 2025, denotes…
Evolving Market Trends In The Biosimilars Industry: Innovative Product Launched …
The Biosimilars Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Biosimilars Market Size During the Forecast Period?
The dimension of the biosimilars market has experienced substantial expansion in the last few years. The market value, which was at $18.65 billion in 2024,…
Prominent Rituximab Biosimilars Market Trend for 2025: Collaborative Innovations …
Which drivers are expected to have the greatest impact on the over the rituximab biosimilars market's growth?
The rituximab biosimilars market is anticipated to grow due to the projected increase in non-Hodgkin's lymphoma (NHL) cases. NHL is a cancer that originates in the white blood cells and lymphocytes, which are integral parts of the body's immune system. For example, the American Cancer Society, a cancer advocacy group based in the US,…
Global Oncology Biosimilars Market | Global Oncology Biosimilars Industry | Onco …
The oncology biosimilars market involves of sales of medicine and drug interrelated products for cancer treatment. Biosimilars are pharmaceuticals which are produced using cell lines and are fashionable to the manufacturer. The manufacturing of such cell line processes is a multipart and time-consuming procedure.
According to the report analysis, ‘Oncology Biosimilars Market Global Report 2020-30’ states that the worldwide oncology biosimilars market was worth USD 2990.34 million in 2019. It is…
Global Biosimilars Market | Global Biosimilars Industry | Global Biosimilars Mar …
The biosimilars market involves of sales of biosimilars and associated services that are cast-off to treat chronic sicknesses such as diabetes, arthritis, and cancer. The Biosimilars are pharmaceuticals that are produced using cell lines and offers no clinical difference as linked to biologics. The Biosimilars are made once the patent of biologics is deceased.
According to the report analysis, ‘Biosimilars Market Global Report 2020-30’ states that the worldwide biosimilars market was…
Insulin Biosimilars Market, by Biosimilar Type Rapid-acting Biosimilars, Long-ac …
Diabetes is a group of metabolic disease characterized by high blood sugar level due to inadequate secretion of insulin. Common symptoms of diabetes include increased hunger, tiredness, weight loss, and excessive thirst and urination. The prevalence of diabetes is increasing, in turn, boosting demand for insulin biosimilar. For instance, according the World Health Organization (WHO) report in 2014, globally around 422 million adults were living with diabetes and 1.5 million…